Premium
Results of chemotherapy in advanced carcinoma of the fallopian tube
Author(s) -
Peters William A.,
Andersen Willie A.,
Hopkins Michael P.
Publication year - 1989
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19890301)63:5<836::aid-cncr2820630507>3.0.co;2-5
Subject(s) - medicine , cisplatin , fallopian tube , chemotherapy , combination chemotherapy , oncology , stage (stratigraphy) , combination therapy , carcinoma , gynecology , surgery , paleontology , biology
Forty‐six patients with measurable disease received chemotherapy for advanced primary or recurrent carcinoma of the fallopian tube. The response rate was 9% with single‐agent therapy, 29% with multiagent therapy without cisplatin, and 81% with cisplatin‐containing combination therapy. Survival was significantly improved in Stage III/IV with the addition of cisplatin‐based combination therapy.